Galderma has reported positive results from a clinical study of Restylane Volyme in Chinese patients with temple hollowing. The company said the study showed high effectiveness, patient satisfaction and a strong safety profile. Study evaluates effectiveness in 162 patients The randomised, evaluator-blinded study involved 162 adults across six sites in China. Researchers divided participants into treatment and no-treatment groups using ...